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Tuning-up transcription
Eukaryotic transcription is a complex process, and recent results identify
multiple steps that need to be stimulated to activate transcription, one of
which is a change in conformation of the general transcription factor TFIIB.
The regulation of transcription appears to be a much
more complex affair in eukaryotes than in bacteria. In
bacteria, a single core RNA polymerase carries the bur-
den of transcribing the entire genome. Temporal and
promoter specificity are conferred upon this polymerase
by the sigma () family of transcription factors. In
eukaryotes, by contrast, different classes of genes are tran-
scribed by distinct enzymes - RNA polymerases I, II
and III. Although the polymerases have diversified to
meet their specialized functions, they have a number of
common features. Thus, each requires a set of auxiliary
factors for accurate transcriptional initiation. One such
factor, essential to the function of each RNA poly-
merase, is a dynamic, multisubunit complex composed of
the TATA binding protein (TBP) and a set of poly-
merase-specific TBP-associated factors (TAFs). The
TBP-TAF complex has different names in its different
guises: the RNA polymerase I version is called SL1, the
RNA polymerase II version is the well-known TFIID,
and the RNA polymerase III version is TFIIIB [1].
The TAFs associated with SL1 and TFIIIB are function-
ally different from those in TFIID. The SL1 and TFIIIB
TAFs function in a way that appears to be analogous to
the RNA polymerase II 'general transcription factors', as
they are required for the formation of transcription com-
petent complexes [2]. The TFIID TAFs, on the other
hand, are dispensable for a basal level of transcription -
and thus for the formation of RNA polymerase II tran-
scription complexes - but essential for the activation of
transcription above the basal rate ('coactivator' function).
In addition to the TBP-TAF complexes, each of the
polymerases requires additional factors for transcription
at specific start sites in vitro [2]. The RNA polymerase II
transcription system displays greater complexity as it
requires, in addition to TFIID, six other general tran-
scription factors. These include TFIIA, TFIIB, TFIIE,
TFIIF, TFIIH, and TFIIJ [3].
One of the most striking findings to emerge from recent
studies of transcription is the high degree of conservation
of factors among such evolutionarily diverged organisms
as yeast, fruitflies, and humans. While most of the general
transcription factors are highly conserved, one aspect in
which the systems were thought to differ was in the
composition and activity of purified TFIID. Human and
Drosophila TFIID were originally purified as large
(>700kD) complexes containing TBP and many TAFs
[4]. Yeast TFIID, in contrast, was first purified as the
single 27kD TBP. The ability of mammalian activators
to function in yeast cells strongly suggested that yeast
must have TAF homologues.
The first direct indication of the existence of yeast TAFs
came from the work of Poon and Weil [5], who found a
series of polypeptides that co-immunopurified with TBP
from yeast whole-cell extracts. A complex was isolated
containing a 70 kD TAF, subsequently identified as BRF1
(TDS4/PCF4), a subunit of the yeast RNA polymerase
III factor TFIIIB [6]. While this complex did not func-
tion in RNA polymerase II transcription, it did support
in vitro transcription of a tRNA gene, when supple-
mented with TFIIIC and RNA polymerase III. These
studies therefore demonstrated the existence of TAFs in
yeast, yet they did not provide an indication of coactiva-
tor function. Further evidence of the existence of yeast
TFIID TAFs was provided by Verrijzer et al. [7] who
reported that Drosophila dTAFn11 50 is homologous to the
product of the essential yeast gene TSM-1.
Green and coworkers [8] have recently reported bio-
chemical evidence supporting the existence of yeast
TAFIIs. They have managed to isolate a TAFII complex
from yeast whole cell extracts by TBP-affinity chro-
matography. While the unbound fraction was able to
support basal transcription, transcriptional activation
required the addition of a fraction eluted from the col-
umn under high ionic conditions. The authors found
that this TAF complex consisted of nine polypeptides,
ranging in size from 30-180kD. This complex specifi-
cally mediated transcriptional activation without affecting
basal activity. The proteins in this yeast TAF complex
clearly play a critical role in the yeast cell, as it was found
that at least two of them, TAF1 90 and TAFII145, are
essential for viability [8]. These polypeptides also show
homology to Drosophila and human TAFs. Consistent
with these findings, Poon and colleagues (D. Poon,
Y. Bai, A.M.Campbell, S. Bjorklund, Y-J. Kim, S. Zhou,
R.D. Kornberg and P.A. Weil, personal communication)
have recently isolated a TFIID-like complex from yeast
cells that has several polypeptides in common with the
complex isolated by Reese et al. [8]. The collective data
from the Green and Weil laboratories demonstrate that
yeast cells contain homologues of human and Drosophila
TAF1i250, TAF11150, TAF1 i80 and TAF1160.
What roles do the TAFs play in the activation of
transcription? Several TAFs have been found to interact
with specific transcriptional activators, suggesting that the
TBP-TAF complex may mediate the response of the
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Fig. 1. A model for the VP16-induced
conformation change in TFIIB, demon-
strated by the recent work of Roberts
and Green [18]. This change makes
TFIIB more accessible to RNA poly-
merase II and TFIIF. The implication is
that the equivalent interaction between
an acidic activator and TFIIB bound to a
promoter would facilitate entry of RNA
polymerase II and TFIIF, thus promoting
preinitiation complex formation and
increasing the rate of transcription.
transcription complex to a broad spectrum of activators.
For example, dTAF 110 interacts with Sp [9] and
dTAF 1I40 interacts with the strong viral activator VP16
[10]. Indeed, by reconstituting dTFIID from recombi-
nant components, Chen et al. [11] have identified specific
TAFs that are required for specific activators to function
in vitro.
The TFIID TAFs, though essential, are not the only par-
ticipants in transcriptional activation. Studies by a num-
ber of laboratories have demonstrated interactions
between specific activators and general transcription fac-
tors, though so far the list of targets is limited to TBP,
TFIIB and TFIIH. The Greenblatt laboratory originally
reported that TBP interacts with VP16 [12]. The Green
laboratory found that an acidic activator can enhance the
recruitment of TFIIB into the transcription complex
[13], and went on to demonstrate a direct physical inter-
action between recombinant activator and recombinant
TFIIB [14]. Specific amino-acid substitutions of TFIIB
and VP16 were identified that compromise their mutual
interaction; these substitutions were found also to cause
defects in activated, but not basal, transcription, thus
demonstrating the functional significance of the TFIIB-
VP16 interaction [15,16]. Since these initial findings
with acidic activators, other activators have been found
also to interact with TFIIB.
TFIIB has been dissected into two domains [17]: an
amino-terminal portion that interacts with TFIIF, and
a carboxy-terminal portion that interacts with RNA
polymerase II, TBP and VP16. Recent work from the
Green laboratory suggests a mechanism by which VP16
may stimulate transcription through TFIIB. Roberts and
Green [18] found that a deletion in the amino terminus
of TFIIB enhances TFIIB binding to VP16. The authors
demonstrated that TFIIB's amino terminus interacts with
its carboxy terminus, blocking the latter's interaction
with VP16. When TFIIB is in such a 'closed' conforma-
tion, it would be relatively inaccessible to TBP, RNA
polymerase II and TFIIH. Consistent with this model,
binding of VP16 to TFIIB induces an alteration of
the protease-cleavage pattern of TFIIB, indicative of an
activator-induced conformational change [18].
Roberts and Green speculate [18] that TFIIB in this
'open' conformation might be more accessible to the
other components of the basal transcription machinery.
Their model is illustrated in Figure 1. A caveat in inter-
preting these results is that the interaction of VP16 and
TFIIB was analyzed in solution and not in the context of
the transcription complex. As TFIIB participates in basal
transcription - that is, transcription in the absence of an
activator - perhaps VP16-mediated unfolding of TFIIB
accelerates the 'opening of TFIIB', and therefore the
access of RNA polymerase II and associated factors
(IIF/IIE/IIH) to the preinitiation complex. It is likely
that, in the absence of activator, the unfolding of TFIIB
occurs at a much reduced rate.
Interestingly, recent studies have demonstrated that the
TFIIH is also a target of VP16 [19]. TFIIH has been
shown to play a role in the 'promoter clearance' phase of
transcription, the phase in which the initiating RNA
polymerase II is converted into an elongation-competent
form and becomes capable of escaping the promoter
[20]. The efficiency of activation of the RNA poly-
merase II transcription system is impressive: a single
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activator such as VP16, by virtue of its contacts with 
TFIIB and TFIIH, could influence both the entry and 
re-entry of R N A  polymerase I1 to the promoter (medi- 
ated by the recruitment of TFIIB), as well as the escape 
of the enzyme from the promoter (mediated by interac- 
tion with TFIIH). If .the regulation of TFIIB were 
uncoupled from the regulation of TFIIH, then the newly 
reformed complexes would have nowhere to go, becom- 
ing log-jammed behind complexes that have not yet 
cleared to the elongation phase. 
The complexity of activation extends beyond the TFIID 
complex and interactions between TAFs, general tran- 
scription factors and activators. Other 'coactivators' have 
been identified that are required for activation, yet are 
distinct from those in the TFIID complex [21,22]. 
Studies from Young's and Kornberg's groups have raised 
the intriguing possibility that preformed complexes com- 
prising general transcription factors and many of the 
coactivators occur in the cell [23,24]. These holoen- 
zyme-mediator complexes could provide a means for 
activators to recruit many of the components required for 
activation in one fell ;woop, rather than sequentially. 
Although the yeast holoenzyme complex has not yet 
been completely characterized, it is known to contain 
R N A  polymerase 11, multiple SRB (suppressor of R N A  
Fig. 2. A model showing some of the 
steps in the transcription cycle that may 
be influenced by activators. Activators 
can stabilize the function of preinitia- 
tion complexes (top), promote recycling 
of TFllB to complexes that remain 
bound at the promoter, or stimulate pro- 
moter clearance by interacting with 
TFllH (bottom). 
polymerase B) proteins [23], GALll/SPT13 (a protein 
thought to be involved in the transcriptional activation of 
a number of genes) [24] and apparently some general 
transcription factors. 
Several lines of evidence argue against a one-step recruit- 
ment model for activation, however. First, TFIIF is 
thought to be the only general transcription factor pre- 
sent in stoichiometric amounts in the holoenzyme com- 
plex, suggesting that the other general transcription 
factors must s td  assemble in a stepwise fashion indepen- 
dently of the holoenzyme. Second, the recruitment of 
TFIIB to the TFIID-TATA complex remains a prerequi- 
site for the loading of R N A  polymerase I1 onto the pro- 
moter. Third, even if all the general transcription factors 
and other coactivators are present in the holoenzyme, 
activators are still likely to influence steps subsequent to 
initiation, such as promoter clearance (P. Kumar and 
D.R., unpublished results). The model dustrated in 
Figure 2 shows some of the steps in transcription that can 
be influenced by activators. 
The studes by the Green laboratory and others provide 
the first insight into the mechanism by which a general 
transcription factor, TFIIB, can mediate transcriptional 
activation. A more precise delineation of the steps involved 
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in activation is forthcoming, as many groups are taking
advantage of the powerful genetic approaches possible
in yeast to dissect the mechanisms of transcriptional
activation. The discovery of RNA polymerase II TAFs in
yeast lends further credence to the notion that the basic
components of the transcriptional activation machinery
are well conserved in evolution. Hence, yeast provide a
useful and relevant model for the study of the mechanism
of transcriptional activation in eukaryotes.
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